Open AccessDelayed emergence of oseltamivir‐resistant seasonal influenza A (H1N1) and pandemic influenza A(H1N1)pdm09 viruses in Myanmar
Author(s) -
Dapat Clyde,
Saito Reiko,
Kyaw Yadanar,
Myint Yi Yi,
Oo Htun Naing,
Oo Khin Yi,
Naito Makoto,
Hasegawa Go,
Dapat Isolde C.,
Suzuki Hiroshi
Publication year - 2013
Publication title -
influenza and other respiratory viruses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.743
H-Index - 57
eISSN - 1750-2659
pISSN - 1750-2640
DOI - 10.1111/irv.12030
Subject(s) - oseltamivir , pandemic , virology , virus , human mortality from h5n1 , seasonal influenza , influenza a virus , transmission and infection of h5n1 , biology , h1n1 pandemic , amantadine , h5n1 genetic structure , covid-19 , influenza a virus subtype h5n1 , medicine , infectious disease (medical specialty) , disease , avian influenza virus
Please cite this paper as: Dapat et al. (2012) Delayed emergence of oseltamivir‐resistant seasonal influenza A (H1N1) and pandemic influenza A(H1N1)pdm09 viruses in Myanmar. Influenza and Other Respiratory Viruses DOI: 10.1111/irv.12030. The prevalence and timing of emergence of oseltamivir‐resistant seasonal and pandemic influenza A (H1N1) viruses in Myanmar in 2008 and 2009 are described in this report. In 2008, the oseltamivir‐resistant seasonal H1N1 virus was detected at a lower rate (6%) and emerged at least 2 months later when compared with neighboring countries. Similarly, the prevalence of pandemic H1N1 virus was low (3%) and the timing of emergence was late (August 2009) in Myanmar. Interestingly, we detected three isolates that were resistant to both amantadine and oseltamivir. Limited movement of people into the country is attributed to the delayed emergence of drug‐resistant seasonal and pandemic A(H1N1) viruses.